FDA Clears First AI Algorithm to Diagnose Cardiac Amyloidosis

Anumana has received FDA approval for its ECG-AI algorithm designed to support the diagnosis of cardiac amyloidosis at the point of care. This makes it the first and only AI algorithm cleared by the FDA for this severe heart condition, which is often missed by the human eye when looking at electrocardiogram (ECG) data.